294 related articles for article (PubMed ID: 10726794)
1. Latanoprost: experience of 2-year treatment in Scandinavia.
Alm A; WidengÄrd I
Acta Ophthalmol Scand; 2000 Feb; 78(1):71-6. PubMed ID: 10726794
[TBL] [Abstract][Full Text] [Related]
2. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.
Alm A; Stjernschantz J
Ophthalmology; 1995 Dec; 102(12):1743-52. PubMed ID: 9098273
[TBL] [Abstract][Full Text] [Related]
3. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group.
Camras CB
Ophthalmology; 1996 Jan; 103(1):138-47. PubMed ID: 8628544
[TBL] [Abstract][Full Text] [Related]
4. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.
Watson P; Stjernschantz J
Ophthalmology; 1996 Jan; 103(1):126-37. PubMed ID: 8628543
[TBL] [Abstract][Full Text] [Related]
5. A 6-month, randomized, double-masked comparison of latanoprost with timolol in patients with open angle glaucoma or ocular hypertension.
Friström B
Acta Ophthalmol Scand; 1996 Apr; 74(2):140-4. PubMed ID: 8739678
[TBL] [Abstract][Full Text] [Related]
6. Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups.
Camras CB; Alm A; Watson P; Stjernschantz J
Ophthalmology; 1996 Nov; 103(11):1916-24. PubMed ID: 8942890
[TBL] [Abstract][Full Text] [Related]
7. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
Netland PA; Landry T; Sullivan EK; Andrew R; Silver L; Weiner A; Mallick S; Dickerson J; Bergamini MV; Robertson SM; Davis AA;
Am J Ophthalmol; 2001 Oct; 132(4):472-84. PubMed ID: 11589866
[TBL] [Abstract][Full Text] [Related]
8. Comparison of brimonidine/latanoprost and timolol/dorzolamide: two randomized, double-masked, parallel clinical trials.
Zabriskie N; Netland PA;
Adv Ther; 2003; 20(2):92-100. PubMed ID: 12836809
[TBL] [Abstract][Full Text] [Related]
9. A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study.
Mishima HK; Masuda K; Kitazawa Y; Azuma I; Araie M
Arch Ophthalmol; 1996 Aug; 114(8):929-32. PubMed ID: 8694726
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of latanoprost in reducing intraocular pressure in patients with primary angle-closure glaucoma.
Chew PT; Hung PT; Aung T
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S125-8. PubMed ID: 12204708
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary study.
Aung T; Wong HT; Yip CC; Leong JY; Chan YH; Chew PT
Ophthalmology; 2000 Jun; 107(6):1178-83. PubMed ID: 10857840
[TBL] [Abstract][Full Text] [Related]
12. Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study.
Higginbotham EJ; Olander KW; Kim EE; Grunden JW; Kwok KK; Tressler CS;
Arch Ophthalmol; 2010 Feb; 128(2):165-72. PubMed ID: 20142538
[TBL] [Abstract][Full Text] [Related]
13. Comparison of latanoprost monotherapy to dorzolamide combined with timolol in patients with glaucoma and ocular hypertension.A 3-month randomised study.
Emmerich KH
Graefes Arch Clin Exp Ophthalmol; 2000 Jan; 238(1):19-23. PubMed ID: 10664047
[TBL] [Abstract][Full Text] [Related]
14. A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
Topouzis F; Melamed S; Danesh-Meyer H; Wells AP; Kozobolis V; Wieland H; Andrew R; Wells D
Eur J Ophthalmol; 2007; 17(2):183-90. PubMed ID: 17415690
[TBL] [Abstract][Full Text] [Related]
15. Latanoprost : an update of its use in glaucoma and ocular hypertension.
Perry CM; McGavin JK; Culy CR; Ibbotson T
Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
[TBL] [Abstract][Full Text] [Related]
16. Phase III latanoprost studies in Scandinavia, the United Kingdom and the United States.
Alm A; Camras CB; Watson PG
Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S105-10. PubMed ID: 9154285
[TBL] [Abstract][Full Text] [Related]
17. The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. a 6-month, randomized, multicenter study. German Latanoprost Study Group.
Diestelhorst M
Graefes Arch Clin Exp Ophthalmol; 2000 May; 238(5):433-9. PubMed ID: 10901475
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension.
Zhang WY; Po AL; Dua HS; Azuara-Blanco A
Br J Ophthalmol; 2001 Aug; 85(8):983-90. PubMed ID: 11466259
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost.
Stewart WC; Day DG; Sharpe ED; Dubiner HB; Holmes KT; Stewart JA
Am J Ophthalmol; 1999 Dec; 128(6):692-6. PubMed ID: 10612504
[TBL] [Abstract][Full Text] [Related]
20. Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trial.
Higginbotham EJ; Feldman R; Stiles M; Dubiner H;
Arch Ophthalmol; 2002 Jul; 120(7):915-22. PubMed ID: 12096962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]